PULMONX CORPORATION Proceeds from Maturities, Prepayments and Calls of Short-term Investments
PULMONX CORPORATION (LUNG) reported Proceeds from Maturities, Prepayments and Calls of Short-term Investments of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments · last filed 2026-08-04
- PULMONX CORPORATION proceeds from maturities, prepayments and calls of short-term investments for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- PULMONX CORPORATION proceeds from maturities, prepayments and calls of short-term investments for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- PULMONX CORPORATION proceeds from maturities, prepayments and calls of short-term investments for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- PULMONX CORPORATION proceeds from maturities, prepayments and calls of short-term investments for the quarter ending 2025-09-30 was $8.80M, a 30.98% decline year-over-year.
- PULMONX CORPORATION proceeds from maturities, prepayments and calls of short-term investments for fiscal 2025 was $36.59M, a 21.89% decline from fiscal 2024.
- PULMONX CORPORATION proceeds from maturities, prepayments and calls of short-term investments for fiscal 2024 was $46.84M, a 4.08% increase from fiscal 2023.
- PULMONX CORPORATION proceeds from maturities, prepayments and calls of short-term investments for fiscal 2023 was $45.00M, a 1.63% increase from fiscal 2022.
- PULMONX CORPORATION proceeds from maturities, prepayments and calls of short-term investments for fiscal 2022 was $44.28M, a 342.80% increase from fiscal 2021.
| Period end | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 3 month | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 6 month | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 9 month | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $0.00 10-Q · filed 2026-08-04 | $0.00 derived: sum of 3 quarters · filed 2026-08-04 | $8.80M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-04 | $0.00 derived: sum of 2 quarters · filed 2026-05-04 | $8.80M derived: sum of 3 quarters · filed 2026-05-04 | $16.05M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $8.80M derived: sum of 2 quarters · filed 2026-03-10 | $16.05M derived: sum of 3 quarters · filed 2026-08-04 | $36.59M 10-K · filed 2026-03-10 |
| 2025-09-30 | $8.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $16.05M derived: sum of 2 quarters · filed 2026-08-04 | $36.59M 10-Q · filed 2025-11-12 | $52.26M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $7.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $27.79M 10-Q · filed 2026-08-04 | $43.46M derived: sum of 3 quarters · filed 2026-08-04 | $56.21M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $20.54M 10-Q · filed 2026-05-04 | $36.21M derived: sum of 2 quarters · filed 2026-05-04 | $48.96M derived: sum of 3 quarters · filed 2026-05-04 | $55.62M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $15.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $28.42M derived: sum of 2 quarters · filed 2026-03-10 | $35.09M derived: sum of 3 quarters · filed 2026-03-10 | $46.84M 10-K · filed 2026-03-10 |
| 2024-09-30 | $12.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $19.41M derived: sum of 2 quarters · filed 2025-11-12 | $31.16M 10-Q · filed 2025-11-12 | $33.41M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $6.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $18.41M 10-Q · filed 2025-08-01 | $20.66M derived: sum of 3 quarters · filed 2025-08-01 | $37.91M derived: sum of 4 quarters · filed 2025-08-01 |
| 2024-03-31 | $11.75M 10-Q · filed 2025-05-02 | $14.00M derived: sum of 2 quarters · filed 2025-05-02 | $31.25M derived: sum of 3 quarters · filed 2025-05-02 | $43.00M derived: sum of 4 quarters · filed 2025-05-02 |
| 2023-12-31 | $2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $19.50M derived: sum of 2 quarters · filed 2025-02-25 | $31.25M derived: sum of 3 quarters · filed 2025-02-25 | $45.00M 10-K · filed 2025-02-25 |
| 2023-09-30 | $17.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | $29.00M derived: sum of 2 quarters · filed 2024-11-01 | $42.75M 10-Q · filed 2024-11-01 | $52.50M derived: sum of 4 quarters · filed 2024-11-01 |
| 2023-06-30 | $11.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $25.50M 10-Q · filed 2024-08-02 | $35.25M derived: sum of 3 quarters · filed 2024-08-02 | $50.50M derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | $13.75M 10-Q · filed 2024-05-03 | $23.50M derived: sum of 2 quarters · filed 2024-05-03 | $38.75M derived: sum of 3 quarters · filed 2024-05-03 | $53.78M derived: sum of 4 quarters · filed 2024-05-03 |
| 2022-12-31 | $9.75M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $25.00M derived: sum of 2 quarters · filed 2024-02-27 | $40.03M derived: sum of 3 quarters · filed 2024-02-27 | $44.28M 10-K · filed 2024-02-27 |
| 2022-09-30 | $15.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $30.28M derived: sum of 2 quarters · filed 2023-11-03 | $34.53M 10-Q · filed 2023-11-03 | $37.53M derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | $15.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $19.28M 10-Q · filed 2023-08-04 | $22.28M derived: sum of 3 quarters · filed 2023-08-04 | $26.78M derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $4.25M 10-Q · filed 2023-05-08 | $7.25M derived: sum of 2 quarters · filed 2023-05-08 | $11.75M derived: sum of 3 quarters · filed 2023-05-08 | $14.25M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $7.50M derived: sum of 2 quarters · filed 2023-03-01 | $10.00M derived: sum of 3 quarters · filed 2023-03-01 | $10.00M 10-K · filed 2023-03-01 |
| 2021-09-30 | $4.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $7.00M derived: sum of 2 quarters · filed 2022-11-08 | $7.00M 10-Q · filed 2022-11-08 | $7.00M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $2.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $2.50M 10-Q · filed 2022-08-08 | $2.50M derived: sum of 3 quarters · filed 2022-08-08 | $2.50M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-09 | $0.00 derived: sum of 2 quarters · filed 2022-05-09 | $0.00 derived: sum of 3 quarters · filed 2022-05-09 | $3.50M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $0.00 derived: sum of 2 quarters · filed 2022-03-01 | $3.50M derived: sum of 3 quarters · filed 2022-03-01 | $13.61M 10-K · filed 2022-03-01 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $3.50M derived: sum of 2 quarters · filed 2021-11-09 | $13.61M 10-Q · filed 2021-11-09 | $19.34M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $3.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $13.61M 10-Q · filed 2021-08-10 | $19.34M derived: sum of 3 quarters · filed 2021-08-10 | |
| 2020-03-31 | $10.11M 10-Q · filed 2021-05-12 | $15.84M derived: sum of 2 quarters · filed 2021-05-12 | ||
| 2019-12-31 | $5.73M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $7.94M 10-K · filed 2021-03-15 | ||
| 2019-09-30 | $2.21M 10-Q · filed 2020-11-13 | |||
| 2018-12-31 | $500.00K 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |